Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label GSK2586184 in moderate to severe ulcerative colitis
NL-OMON38611Active, not recruiting
- Sponsor
- GSK
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of solcitinib in autoimmune colitis, sponsored by GSK. Primary endpoint: Adverse events. Started Jan 2014; status: active, not recruiting.
02
Drugs
solcitinib
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on NL-OMON38611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38611.